ARTA
CCXI

A.R.T. Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

A.R.T. Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,176
Closed -$243K – 1827
2019
Q2 		$243K Buy
26,176
+2,300
+10% +$26.6K 0.01% 1032
2019
Q1 		$332K Buy
+23,876
New +$273K 0.02% 897
2018
Q1 		– Sell
-11,297
Closed -$67K – 1832
2017
Q4 		$67K Buy
+11,297
New +$77.5K ﹤0.01% 1281
2014
Q1 		– Sell
-33,501
Closed -$193K – 1620
2013
Q4 		$193K Buy
33,501
+12,000
+56% +$61.9K 0.01% 1135
2013
Q3 		$119K Sell
21,501
-8,101
-27% -$87.6K 0.01% 1201
2013
Q2 		$418K Buy
+29,602
New +$384K 0.01% 946

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

A.R.T. Advisors's CCXI Position: Q3 2019 in Review

A.R.T. Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q3 2019, closing a stake of 26,176 shares — an estimated $243K sold.

A.R.T. Advisors first reported a position in CCXI in Q2 2013 and held it in 6 quarters. The position peaked at $418K in Q2 2013. 100 funds tracked by Wall St. Rank hold CCXI as of Q3 2019.

  • A.R.T. Advisors reported no remaining ChemoCentryx, Inc. position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 26,176 ChemoCentryx, Inc. shares in Q3 2019, an estimated $243K.
  • A.R.T. Advisors first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 6 quarters.
  • A.R.T. Advisors's ChemoCentryx, Inc. position peaked at $418K in Q2 2013.
  • 100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.